Top 10 food allergy stories of 2025
The first documented alpha-gal syndrome fatality from mammalian meat dominated our most popular food allergy coverage in 2025.
Other top stories focused on a new protocol that resulted in two toddlers who had peanut allergy during infancy being able to safely consume peanuts and the psychosocial burden children with food allergy face.
Check out the list below for our most-read stories about food allergy of the year.
First documented alpha-gal syndrome fatality from mammalian meat reported
Researchers have documented the first fatality due to alpha-gal syndrome after consumption of mammalian meat, according to data published in The Journal of Allergy and Clinical Immunology: In Practice. Thomas A.E. Platts-Mills, MD, PhD, professor of medicine in asthma, allergy and immunology at the University of Virginia School of Medicine, discussed the findings. Plus, Douglas H. Jones, MD, FAAAI, FACAAI, cofounder and CEO of the Food Allergy Support Team and member of Healio’s Allergy/Asthma Peer Perspective Board, and Sharon Forsyth, executive director of the Alpha-gal Alliance Action Fund, share their thoughts on the news. Read more.
Use of raw then roasted peanuts reverses allergy for two infants
Two toddlers who had peanut allergy during infancy are now able to safely consume peanuts following a new protocol, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting. Rachel Kado, MD, allergist and immunologist with the Kado Clinic in Bloomfield Hills, Michigan, discussed the results and what’s next. Read more.
Children with food allergy face ‘substantial’ psychosocial burden
Children with food allergy face a substantial psychosocial burden regardless of their sociodemographic or clinical characteristics, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice. Melissa L. Engel, PhD, postdoctoral fellow, Center for Food Allergy and Asthma Research (CFAAR), Feinberg School of Medicine, discussed the findings. Read more.
Myths of food sensitivity tests: What you need to know
In his APEX Award-winning column, Food Allergy: Fact vs. Fiction, Healio Allergy/Asthma Peer Perspective Board Member Douglas H. Jones, MD, breaks down five myths surrounding food sensitivity tests and what the evidence actually says. Read more.
Anaphylaxis drives call to add four food allergens to mandatory labels
Goat’s and sheep’s milk, buckwheat, peas and lentils, and pine nut are allergens that could be added to the European mandatory labeling of foods list based on their presence in cases of severe food anaphylaxis, according to study data published in Clinical & Experimental Allergy. Xavier Van der Brempt, MD, PhD, pulmonologist, allergist and group leader at Clinique Saint-Luc Bouge in Belgium, discussed the impact of the results. Read more.
Early blueberry consumption may aid in resolving allergic symptoms, benefit immune system
Some infants fed blueberry powder every day from age 5 months to 12 months had resolved respiratory symptoms, whereas this was not achieved by any infants fed an isocaloric placebo powder, according to data published in Nutrients. Carina Venter, PhD, RD, professor of pediatrics in the section of allergy/immunology at the University of Colorado Anschutz Medical Campus, discussed the trial’s findings. Plus, Lena Bakovic, MS, RDN, CNSC, registered dietitian nutritionist specializing in gut health, heart disease, diabetes, weight management, intuitive eating and general health and wellness at Live it Up, shares her Perspective on this study. Read more.
Peanut patch safe, effective in toddlers 3 years after placebo use
Toddlers with a peanut allergy built tolerance with 3 years of epicutaneous immunotherapy after a year of placebo use, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting. Read more.
Sequencing identifies specific milk protein causing eosinophilic esophagitis
Gene sequencing enabled researchers to identify the specific milk protein that triggered a patient’s eosinophilic esophagitis, according to a study published in The Journal of Allergy and Clinical Immunology. David A. Hill, MD, PhD, attending physician with the division of allergy and immunology at Children’s Hospital of Philadelphia, discussed the results. Read more.
Families ‘thrilled’ with omalizumab in the year since its approval for food allergy
As we approached the first anniversary of omalizumab’s approval for food allergy, Robert A. Wood, MD, FAAAAI, professor of pediatrics, Johns Hopkins University School of Medicine, told Healio that its use is “definitely going to grow.” Zachary E. Rubin, MD, pediatric allergist at Oak Brook Allergists, also shares his Perspective. Read more.
Peanut consumption safe 3 years after end of oral immunotherapy treatment
Most children who achieved remission with peanut oral immunotherapy continued to eat peanuts freely 3 years after treatment, according to a long-term study of a phase 2b trial population. Mimi Tang, PhD, scientific founder of Prota Therapeutics and director of the Allergy Translation Centre and head of allergy immunology at Murdoch Children’s Research Institute, discussed PRT120 (Prota Therapeutics) and study findings. Read more.
Perspective
Back to Top
The most read food allergy stories of 2025 combined urgency with optimism. The first documented fatality from alpha-gal syndrome emphasized the potentially life-threatening nature of emerging food allergies. In contrast, multiple reports detailed advances in peanut allergy management, including early-life raw-then-roasted introduction protocols, long-term success following oral and epicutaneous immunotherapy, and sustained peanut consumption years after treatment. The first year of FDA approval of omalizumab for food allergy marked a major therapeutic milestone, while molecular sequencing studies identifying specific milk proteins in eosinophilic esophagitis pointed toward increasingly precise, personalized care. Additionally, research on early dietary interventions and the substantial psychosocial burden faced by children with food allergy broadened the narrative beyond immunology alone.
Sources/Disclosures
Source:
Healio Coverage
Ask a clinical question and tap into Healio AI's knowledge base.
- PubMed, enrolling/recruiting trials, guidelines
- Clinical Guidance, Healio CME, FDA news
- Healio's exclusive daily news coverage of clinical data
Read more about
